Menu
Washingtoner
  • Home
  • Financial
  • Boeing
  • Aerospace
  • Technology
  • Daryl Guberman
  • Non-profit
  • ANSI-ANAB
  • Health
Washingtoner

FreezeNit Announces Exclusive Licensing of Novel Non-Toxic Lice Treatment Technology
Washingtoner/10287890

Trending...
  • Spokane: Statement From Mayor Brown, Council President Wilkerson, And Chief Hall On 20th Anniversary Of Otto Zehm's Death
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • The State of Law Firm Marketing: Top Companies, Awards, and Resources
FreezeNit
Naturally-Derived OTC Gel Eliminates Lice Without Neurotoxins, Launching Spring 2025

MARBLEHEAD, Mass. - Washingtoner -- FreezeNit, a leader in innovative lice treatment solutions, is thrilled to announce the exclusive licensing of a novel over-the-counter (OTC) lice treatment gel designed to provide a safe, naturally-derived, and highly effective alternative to traditional synthetic or pesticide-based lice treatments.

Unlike conventional OTC lice treatments that rely on pesticide-based pyrethroids, which have decreasing efficacy due to lice resistance, this new technology works by a purely mechanical method of action to eliminate lice and their eggs. The patented formula is free from harsh chemicals and instead leverages natural abrasives, such as diatomaceous earth and walnut shell powder, orange oil extract, and conditioning agents to physically shred lice and nits, while being gentle on the hair and scalp.

This addition strengthens FreezeNit's growing product portfolio, reinforcing the company's mission to provide clean, effective, science-backed treatments that parents can trust.

"This is an incredibly exciting milestone for FreezeNit," said Joanna Shu, CEO of FreezeNit. "By securing exclusive rights to this novel technology, we're positioned to be on the cutting edge of first aid treatments that are gentle on kids. Traditional lice treatments have failed parents and kids, but with this gel, lice don't stand a chance."

More on Washingtoner
  • Tuckwell Machinery Expands CNC Range to Support Australian Cabinet Makers
  • The Inner Power of Emotional Self-Leadership
  • Dr. Nadene Rose Shares the Secret to True Success: Faith, Obedience, and Divine Purpose
  • Spokane: Armed Barricaded Subject Causes N. Market St To Close
  • Enleaf Founder Joins AI Panel at Møde Campus to Help Spokane-Area Businesses Navigate the AI Shift

✔ Clinically Proven – was shown to be 96% effective in a clinical trial.
✔ No Resistance Issues – Unlike permethrin-based treatments, which have seen increased lice resistance, this technology works mechanically—not chemically—so lice cannot develop immunity.
✔ Patented & Protected – This novel formula and method of action is patented in the U.S., Canada, and the EU, ensuring exclusivity in the market.
✔ Class I, 510(k) Exempt – The FDA-regulated status allows for a fast-tracked market entry.

FreezeNit is actively engaging with retailers, distributors, and healthcare providers to bring this breakthrough lice treatment to families everywhere.

FreezeNit is an innovative healthcare company dedicated to revolutionizing first-aid with safe, effective, and science-backed solutions. By leveraging cutting-edge technology and natural alternatives to neurotoxins, FreezeNit provides families with fast, reliable, and pesticide-free treatments for head lice infestations.  For more information, visit www.FreezeNit.com.

Media Contact
Cathy Henry
cathy@freezenit.com
214-924-5992


Source: FreezeNit

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • TicTac Group acquires French EdTech company Distrisoft
  • Suspect Arrested in February Shooting in South Tacoma
  • Tacoma: City's Events and Recognitions Committee Announces the City of Destiny Award Winners
  • Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
  • Genpak Announces Closure of Utah Manufacturing Facility
  • Systemic Certification Breakdown: Federal Oversight Undermined by ANAB Governance Conflicts (2018–2026)
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • The AAA Metamorphosis: How Global Gaming Is Redefining Production Standards
  • Monexplora Explains the Options Mechanics Behind March's Tech Selloff and VIX Surge
  • Spokane: Shooting on Wellesley Leaves One Person Deceased and Another Injured
  • Spokane: District 3 Council Members to Host Community Town Hall
  • Spokane: City Recognizes Local Businesses for Excellent Wastewater Management
  • Tacoma Police Department Increases DUI Patrols
  • Larry R. Wasion Highlights Jump Gate I: Time Chair. The Opening Novel in His Expansive Science Fiction Series
  • New Book Reveals The Science Of Predictions
  • City of Tacoma's Solid Waste Utility Expands 'Beyond the Bin' Community Reuse Events
  • Animal Communicator Vicki Draper Helps Pet Parents Reduce Stress and Improve Behavior Naturally
  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • "FRAUD: Federal Reliance, Regulatory Blindness, ANAB Misrepresentation, Unchecked Conflicts, And Deception -The Guberman Definition
  • Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
_catLbl0 _catLbl1

Popular on Washingtoner

  • Tacoma: Applicants Sought for the Public Utility Board - 153
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Amicly Launches as a Safety-First Social App Designed to Help People Build Real, Meaningful Friendships
  • Spokane: Indian Canyon Golf Course Opens Thursday, March 12, 2026
  • Tacoma: WIAA/Gesa Credit Union Basketball Tournament
  • Spokane: SPD Releases the Names of the Officers Involved in the OIS on Carlisle
  • Spokane: City Council Adopts "Immigration Enforcement Free Zones" Ordinance
  • Independent Financial Agencies Upgrade City of Tacoma’s Bond Ratings Amid Broader Economic Uncertainty
  • Lineus Medical's SafeBreak® Vascular Added to Alliant GPO Contract

Similar on Washingtoner

  • LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
  • The Inner Power of Emotional Self-Leadership
  • Understanding Unexpected Death: Why Independent Autopsies Matter in Cases Without Clear Cause
  • Mark Dobosz Makes Donorassess.org Free To Every Nonprofit On The Planet
  • Newborn Care Network Introduces Clinical Standard to Bridge the Six-Week Postpartum Gap
  • Animal Communicator Vicki Draper Helps Pet Parents Reduce Stress and Improve Behavior Naturally
  • Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
  • NYC Composer/Educator Launches Debut Children's Book to Fantastic Reviews
  • KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
  • Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute